A phase 2 study of TMX-101, intravesical imiquimod, for the treatment of carcinoma in situ bladder cancer - Concepedia

Concepedia

Publication | Closed Access

A phase 2 study of TMX-101, intravesical imiquimod, for the treatment of carcinoma in situ bladder cancer

41

Citations

21

References

2016

Year

Nicholas M. Donin, Karim Chamie, Andrew T. Lenis, Allan J. Pantuck, Madhu Reddy, Dana Kivlin, Johanna Holldack, Rafaella Pozzi, Gil Hakim, Lawrence I. Karsh,

Urologic Oncology Seminars and Original Investigations

Surgical OncologyUrologyGenitourinary CancerSitu Bladder CancerIntravesical ImiquimodMedicineCancer TreatmentPhase 2OncologyRadiation Oncology

References

	Year	Citations

Page 1

Page 1